Aragest_5
Category
Aragest_5 Brand names, Aragest_5 Analogs
Aragest_5 Brand Names Mixture
Lunelle (Medroxyprogesterone + Estradiol)
Aragest_5 Chemical_Formula
C22H32O3
Aragest_5 RX_link
http://www.rxlist.com/cgi/generic/medrox.htm
Aragest_5 fda sheet
Aragest_5 msds (material safety sheet)
Aragest_5 Synthesis Reference
P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)
Aragest_5 Molecular Weight
344.488 g/mol
Aragest_5 Melting Point
220 - 223.5 oC
Aragest_5 H2O Solubility
22.2mg/L
Aragest_5 State
Solid
Aragest_5 LogP
3.606
Aragest_5 Dosage Forms
Tablets; Depo injection
Aragest_5 Indication
Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.
Aragest_5 Pharmacology
Medroxyprogesterone is a synthetic progestin more potent than progesterone.
Aragest_5 Absorption
Rapidly absorbed from GI tract
Aragest_5 Toxicity
Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.
Aragest_5 Patient Information
Aragest_5 Organisms Affected
Humans and other mammals
